Exane BNP Paribas upgraded Comcast (CMCSA) to Neutral from Underperform with a $35 price target Invest with Confidence: Follow TipRanks' Top ...
Exane BNP Paribas analyst Karl Ackerman upgraded Cisco (CSCO) to Outperform from Neutral with a price target of $72, up from $57. The firm sees ...
UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss lender will increase share buybacks. The stock gained as much as 3.8% ...
Medical Properties Trust Inc (MPW) stock saw a decline, ending the day at $4.45 which represents a decrease of $-0.20 or -4.30% from the prior close of $4.65. The stock opened at $4.61 and touched a ...
Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for flatexDEGIRO (OTCPK:FNNTF) from Neutral to Outperform. Analyst Price Forecast Suggests 5.46% Upside As of March ...
Fintel reports that on January 2, 2025, BNP PARIBAS EXANE downgraded their outlook for Unibail-Rodamco-Westfield SE (OTCPK:UNBLF) from Outperform to Neutral. Analyst Price Forecast Suggests 2.83% ...
Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (OTCPK:NONOF) from Neutral to Outperform. As of December 23, 2024, the average one-year price ...
Kellanova (K) stock saw a modest uptick, ending the day at $81.87 which represents a slight increase of $0.10 or 0.12% from the prior close of $81.77. The stock opened at $81.66 and touched a low of ...
Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for flatexDEGIRO (LSE:0W89) from Neutral to Outperform. As of December 23, 2024, the average one-year price target ...
Exane BNP Paribas upgraded Adobe Inc. (NASDAQ:ADBE) to Neutral from Underperform and raised the stock's price target to $425. The analyst views better risks and rewards consideration on Adobe for its ...
Investing.com -- UBS Group AG (SIX:UBSG) shares posted their largest gain in two months, rising by as much as 3.8%, after analysts at BNP Paribas (OTC:BNPQY) Exane upgraded their recommendation to ...